Nature News discusses the controversy surrounding India's Open Source Drug Discovery project's April 11 announcement that its researchers have "comprehensively mapped, compiled, and verified the genome of Myobacterium tuberculosis," and was the first to make it publicly available.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.